delphinidin has been researched along with Lymphoproliferative Disorders in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cerroni, L; Kerl, H; Martinez Aparicio, A; Smolle, J; Soyer, HP | 1 |
| al Saati, T; Brousset, P; Caspar, S; Caverivière, P; Chittal, S; Dastugue, N; Hounieu, H; Icart, J; Idoipe, JB; Mazerolles, C | 1 |
| Medeiros, LJ; Ngan, BY; Picker, LJ; Warnke, RA | 1 |
| Bindl, JM; Butmarc, JR; Pinkus, GS; Said, JW; Shintaku, P; Stoll, PN | 1 |
4 other study(ies) available for delphinidin and Lymphoproliferative Disorders
| Article | Year |
|---|---|
Immunophenotyping of cutaneous lymphoid infiltrates in frozen and paraffin-embedded tissue sections: a comparative study.
Topics: Antibodies, Monoclonal; Biopsy; Fixatives; Frozen Sections; Humans; Immunoenzyme Techniques; Lymphoma; Lymphoproliferative Disorders; Microtomy; Paraffin; Phenotype; Skin; Skin Diseases; Skin Neoplasms | 1990 |
Production of anti-B monoclonal antibodies (DBB.42, DBA.44, DNA.7, and DND.53) reactive on paraffin-embedded tissues with a new B-lymphoma cell line grafted into athymic nude mice.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; B-Lymphocytes; Blotting, Western; Histiocytosis, Langerhans-Cell; Humans; Immunoenzyme Techniques; Karyotyping; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoid Tissue; Lymphoproliferative Disorders; Mice; Mice, Nude; Molecular Weight; Neoplasm Transplantation; Paraffin; T-Lymphocytes; Tumor Cells, Cultured | 1989 |
Immunophenotypic diagnosis of non-Hodgkin's lymphoma in paraffin sections. Co-expression of L60 (Leu-22) and L26 antigens correlates with malignant histologic findings.
Topics: Antibodies, Monoclonal; Antigens, Differentiation; Humans; Immunohistochemistry; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Paraffin; Phenotype | 1989 |
Leu-22: a preferential marker for T-lymphocytes in paraffin sections. Staining profile in T- and B-cell lymphomas, Hodgkin's disease, other lymphoproliferative disorders, myeloproliferative diseases, and various neoplastic processes.
Topics: Antibodies, Monoclonal; B-Lymphocytes; Biomarkers, Tumor; Cell Transformation, Neoplastic; Hodgkin Disease; Humans; Immunohistochemistry; Lymphoma; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Myeloproliferative Disorders; Paraffin; T-Lymphocytes | 1989 |